Recent Updates
Recently added Catalysts
AGEN

Agenus to Report Fourth Quarter and Year-End 2010 Financial Results on February 17, 2011; Conference Call to Follow

Key Takeaway: LEXINGTON, Mass., Feb. 10, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) will release its fourth quarter and full-year financial results before the market opens on February 17, 2011. Agenus executives will host a conference call at 11:00 a.m. Eastern Time that same day. To

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+52%
120-day peak, hindsight
Typical move
6.2%
average across 4 past catalysts
Cash runway
~1 mo
High dilution risk
Lead asset
Botensilimab
Phase 1 · Pancreatic Cancer Metastatic

Full Press Release Details

LEXINGTON, Mass., Feb. 10, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) will release its fourth quarter and full-year financial results before the market opens on February 17, 2011.
Agenus executives will host a conference call at 11:00 a.m. Eastern Time that same day. To access the live call, dial 877.475.3568 (domestic) or 678.809.3092 (international); the access code is 42659717. The call will also be webcast and will be accessible from the company's website at www.agenusbio.com/webcast/. A replay will be available approximately two hours after the call through midnight Eastern Time on August 17, 2011. The replay number is 800.642.1687 (domestic) or 706.645.9291 (international), and the access code is 42659717. The replay will also be available on the company's website approximately two hours after the live call.
Agenus is a biotechnology company developing treatments for cancers and infectious diseases. For more information, please visit www.agenusbio.com.
Last updated: Feb 10, 2011